IL257188A - Pharmaceutical composition with improved storage stability and method for preparing the same - Google Patents

Pharmaceutical composition with improved storage stability and method for preparing the same

Info

Publication number
IL257188A
IL257188A IL257188A IL25718818A IL257188A IL 257188 A IL257188 A IL 257188A IL 257188 A IL257188 A IL 257188A IL 25718818 A IL25718818 A IL 25718818A IL 257188 A IL257188 A IL 257188A
Authority
IL
Israel
Prior art keywords
preparing
pharmaceutical composition
same
storage stability
improved storage
Prior art date
Application number
IL257188A
Other languages
English (en)
Hebrew (he)
Original Assignee
Samyang Biopharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samyang Biopharmaceuticals filed Critical Samyang Biopharmaceuticals
Publication of IL257188A publication Critical patent/IL257188A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL257188A 2015-07-28 2018-01-28 Pharmaceutical composition with improved storage stability and method for preparing the same IL257188A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20150106627 2015-07-28
PCT/KR2016/008267 WO2017018818A1 (fr) 2015-07-28 2016-07-28 Composition pharmaceutique à stabilité au stockage améliorée, et son procédé de préparation

Publications (1)

Publication Number Publication Date
IL257188A true IL257188A (en) 2018-03-29

Family

ID=57885186

Family Applications (1)

Application Number Title Priority Date Filing Date
IL257188A IL257188A (en) 2015-07-28 2018-01-28 Pharmaceutical composition with improved storage stability and method for preparing the same

Country Status (13)

Country Link
EP (1) EP3328435A4 (fr)
JP (1) JP2018521103A (fr)
KR (1) KR101787451B1 (fr)
CN (1) CN106659681A (fr)
AU (1) AU2016299546B2 (fr)
BR (1) BR112018001725A2 (fr)
CA (1) CA2993925A1 (fr)
HK (1) HK1249442A1 (fr)
IL (1) IL257188A (fr)
MX (1) MX2018001221A (fr)
RU (1) RU2018107057A (fr)
WO (1) WO2017018818A1 (fr)
ZA (1) ZA201801188B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102144479B1 (ko) * 2018-05-24 2020-08-13 주식회사 덱스레보 조직 수복용 조성물 및 이의 제조방법
KR102251192B1 (ko) * 2020-08-07 2021-05-13 주식회사 덱스레보 조직 수복용 조성물 및 이의 제조방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1233420C (zh) * 2000-05-12 2005-12-28 株式会社三养社 通过嵌段共聚物的相分离制备聚合物胶束的方法
US7217770B2 (en) * 2000-05-17 2007-05-15 Samyang Corporation Stable polymeric micelle-type drug composition and method for the preparation thereof
CN1303155C (zh) * 2001-10-18 2007-03-07 株式会社三养社 具有改进稳定性的聚合物胶束组合物
EP1967854B8 (fr) 2007-03-06 2010-12-29 Cell Therapeutics, Inc. Procédé pour la détermination de la quantité de taxane conjugué dans des conjugués de taxane-acide polyglutamique
US9801818B2 (en) * 2007-12-31 2017-10-31 Samyang Biopharmaceuticals Corporation Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug
KR101024742B1 (ko) * 2007-12-31 2011-03-24 주식회사 삼양사 탁산 함유 양친성 블록 공중합체 미셀 조성물 및 그 제조방법
US8853351B2 (en) * 2007-12-31 2014-10-07 Samyang Biopharmaceuticals Corporation Highly pure amphiphilic copolymer comprising hydrophobic block from alpha-hydroxy acid and process for the preparation thereof
EP2201935B1 (fr) * 2008-12-26 2020-07-08 Samyang Biopharmaceuticals Corporation Composition de micelles polymères contenant un médicament faiblement soluble et son procédé de préparation
CN102218027B (zh) * 2011-04-22 2014-07-02 上海谊众生物技术有限公司 一种包载难溶性抗肿瘤药物的聚合物胶束冻干制剂
CN103768013A (zh) * 2014-01-17 2014-05-07 丽珠医药集团股份有限公司 以精制两亲性嵌段共聚物为载体的紫杉醇聚合物胶束

Also Published As

Publication number Publication date
BR112018001725A2 (pt) 2018-09-18
EP3328435A4 (fr) 2019-03-13
AU2016299546B2 (en) 2019-05-02
CA2993925A1 (fr) 2017-02-02
RU2018107057A3 (fr) 2019-08-28
KR101787451B1 (ko) 2017-10-19
AU2016299546A1 (en) 2018-03-08
JP2018521103A (ja) 2018-08-02
HK1249442A1 (zh) 2018-11-02
CN106659681A (zh) 2017-05-10
MX2018001221A (es) 2018-04-24
EP3328435A1 (fr) 2018-06-06
RU2018107057A (ru) 2019-08-28
KR20170015199A (ko) 2017-02-08
WO2017018818A1 (fr) 2017-02-02
ZA201801188B (en) 2018-12-19

Similar Documents

Publication Publication Date Title
IL289099A (en) Methods for storage of whole blood, and corresponding preparations
EP3130355A4 (fr) Composition pharmaceutique comprenant de la prégabaline, ayant une stabilité améliorée, et son procédé de préparation
PL3337616T3 (pl) Pojemnik do przyjmowania końcówek pipet oraz sposób jego dostarczania
IL251703B (en) A pharmaceutical preparation with improved stability
ZA201703398B (en) Pharmaceutical composition and methods
HRP20200104T8 (hr) Novi heterociklični spoj, metoda za pripremu istog, i farmaceutska kompozicija koja sadrži isto
HK1214767A1 (zh) 片劑形式的藥物組合物及其製造方法
IL257621B (en) A catechol derivative and a pharmaceutical preparation that includes it
HK1249439A1 (zh) 具有改善的儲存穩定性的藥物組合物及其製備方法
HK1249442A1 (zh) 具有改善的儲存穩定性的藥物組合物及其製備方法
PL3250188T3 (pl) Kompozycja farmaceutyczna zawierająca Aprepitant oraz sposób jej wytwarzania
HK1249440A1 (zh) 具有改善的儲存穩定性的藥物組合物及其製備方法
EP3384933C0 (fr) Composition d'alcool de sucre anhydre ayant une stabilité au stockage accrue et procédé de stockage d'alcool de sucre anhydre
EP3305283A4 (fr) Composition pharmaceutique stabilisée et son procédé de préparation
HK1249441A1 (zh) 具有改善的儲存穩定性的藥物組合物及其製備方法
EP3344661C0 (fr) Complexes de fer-polysaccharide et leurs procédés de préparation
IL230801A0 (en) A solid preparation containing stable sulfur and a method for its production